FDA-certified drug network drug substance LIMOUS or its derivatives CE-certified drug network drug substance LIMOUS or its derivatives

The GENERAL AUTHORITY OF THE MARTYR BASIL AL -ASSAD HOSPITAL in Syria from Middle East region had released this tender for Tenders are invited for FDA-certified drug network drug substance LIMOUS or its derivatives CE-certified drug network drug substance LIMOUS or its derivatives The General Authority of the martyr basil Assad hospital for cardiology and surgery To the Arab advertising foundation The General Authority of the martyr Basil al-Assad hospital for cardiology and surgery in Aleppo announces its desire to announce a request for solicitation of quotations for the supply of medical supplies for the cardiac catheterization Department (expansion) (pharmaceutical networks) for the authority for the year 2023 according to the following table Statement No. 50 initial insurances term of execution price of the book of conditions 1 pharmaceutical network that has an FDA certificate the pharmaceutical substance LIMOUS or its derivatives 50 15,000,000 45 days 25,000 thousand Syrian pounds 42 pharmaceutical networks with CE certification of the drug substance LIMOUS or its derivatives 50 The presentations are submitted to the authority's office within one envelope containing three envelopes – the first is the envelope of the identification papers – the second is the envelope of the technical presentation – and the third is the envelope of the financial presentation The period of the exhibitor's engagement with the offer is six months, which is automatically renewed if there is no objection within the legal period Final insurance 10% of the contract value Books of technical, legal and financial conditions can be obtained from the contracts division after payment of their value in the authority's fund Fragmentary offers are accepted for each subject separately The deadline for submitting offers is the end of the official working day from Sunday, 30/7/2023 Offers open the next day 31/7/2023 [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.] with tender notice no. 103867 published on 17 Jul 2023. The tender expired on 31 Jul 2023. This tender is sourced from Official Website and is eligible for suppliers interested in Pharmaceutical products. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 3334043.